Waldenström macroglobulinemia: 2017 update on diagnosis, risk stratification, and management.
about
Comparative outcomes of immunochemotherapy regimens in Waldenström macroglobulinaemia.Waldenstrom's Macroglobulinemia: A Report of Two Cases, One with Severe Retinopathy and One with Renal Failure.Current applications of multiparameter flow cytometry in plasma cell disorders.The proteasome and proteasome inhibitors in multiple myeloma.Cardiac side effects of bruton tyrosine kinase (BTK) inhibitors.Anticancer Therapy-Induced Atrial Fibrillation: Electrophysiology and Related Mechanisms
P2860
Waldenström macroglobulinemia: 2017 update on diagnosis, risk stratification, and management.
description
2017 nî lūn-bûn
@nan
2017 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Waldenström macroglobulinemia: ...... tratification, and management.
@ast
Waldenström macroglobulinemia: ...... tratification, and management.
@en
type
label
Waldenström macroglobulinemia: ...... tratification, and management.
@ast
Waldenström macroglobulinemia: ...... tratification, and management.
@en
prefLabel
Waldenström macroglobulinemia: ...... tratification, and management.
@ast
Waldenström macroglobulinemia: ...... tratification, and management.
@en
P2860
P356
P1476
Waldenström macroglobulinemia: ...... tratification, and management.
@en
P2860
P304
P356
10.1002/AJH.24557
P577
2017-02-01T00:00:00Z